240 related articles for article (PubMed ID: 19191052)
1. Clinical review: impact of statin substitution policies on patient outcomes.
Atar D; Carmena R; Clemmensen P; K-Laflamme A; Wassmann S; Lansberg P; Hobbs R
Ann Med; 2009; 41(4):242-56. PubMed ID: 19191052
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
Mullins CD; Rattinger GB; Kuznik A; Koren MJ
Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
[TBL] [Abstract][Full Text] [Related]
3. Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution.
Gumbs PD; Verschuren WM; Souverein PC; Mantel-Teeuwisse AK; de Wit GA; de Boer A; Klungel OH
Br J Clin Pharmacol; 2007 Nov; 64(5):680-5. PubMed ID: 17875197
[TBL] [Abstract][Full Text] [Related]
4. Statins in the intensive care unit.
Merx MW; Weber C
Curr Opin Crit Care; 2006 Aug; 12(4):309-14. PubMed ID: 16810040
[TBL] [Abstract][Full Text] [Related]
5. Preprocedural statin therapy in percutaneous coronary intervention.
Cahoon WD; Crouch MA
Ann Pharmacother; 2007 Oct; 41(10):1687-93. PubMed ID: 17712042
[TBL] [Abstract][Full Text] [Related]
6. Preventing coronary heart disease and stroke with aggressive statin therapy in older adults using a team management model.
Mason CM
J Am Acad Nurse Pract; 2009 Jan; 21(1):47-53. PubMed ID: 19125895
[TBL] [Abstract][Full Text] [Related]
7. Impact of statins on risk of stroke: a meta-analysis.
Henyan NN; Riche DM; East HE; Gann PN
Ann Pharmacother; 2007 Dec; 41(12):1937-45. PubMed ID: 17986516
[TBL] [Abstract][Full Text] [Related]
8. The impact of generic reference pricing interventions in the statin market.
Puig-Junoy J
Health Policy; 2007 Nov; 84(1):14-29. PubMed ID: 17368619
[TBL] [Abstract][Full Text] [Related]
9. [Statins with a perspective of lifelong therapy].
Ertaş FS
Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():29-36. PubMed ID: 19404048
[TBL] [Abstract][Full Text] [Related]
10. Safety of statin therapy in patients with preexisting liver disease.
Onofrei MD; Butler KL; Fuke DC; Miller HB
Pharmacotherapy; 2008 Apr; 28(4):522-9. PubMed ID: 18363535
[TBL] [Abstract][Full Text] [Related]
11. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
[TBL] [Abstract][Full Text] [Related]
12. To switch (statins) or not to switch? That is the question.
Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
Expert Opin Pharmacother; 2010 Dec; 11(18):2943-6. PubMed ID: 20958109
[TBL] [Abstract][Full Text] [Related]
13. Non-adherence to statin therapy: a major challenge for preventive cardiology.
Bates TR; Connaughton VM; Watts GF
Expert Opin Pharmacother; 2009 Dec; 10(18):2973-85. PubMed ID: 19954271
[TBL] [Abstract][Full Text] [Related]
14. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
15. American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively.
McElduff P; Jaefarnezhad M; Durrington PN
Heart; 2006 Sep; 92(9):1213-8. PubMed ID: 16717068
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
Zhao SP; Peng DQ; Yu BL; Huo Y;
Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
[TBL] [Abstract][Full Text] [Related]
17. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.
Fuentes B; Martínez-Sánchez P; Díez-Tejedor E
Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842
[TBL] [Abstract][Full Text] [Related]
18. Statin therapy: a potentially useful peri-operative intervention in patients with cardiovascular disease.
Biccard BM; Sear JW; Foëx P
Anaesthesia; 2005 Nov; 60(11):1106-14. PubMed ID: 16229696
[TBL] [Abstract][Full Text] [Related]
19. Continuation of statin treatment and all-cause mortality: a population-based cohort study.
Shalev V; Chodick G; Silber H; Kokia E; Jan J; Heymann AD
Arch Intern Med; 2009 Feb; 169(3):260-8. PubMed ID: 19204217
[TBL] [Abstract][Full Text] [Related]
20. Statins for surgical patients.
Williams TM; Harken AH
Ann Surg; 2008 Jan; 247(1):30-7. PubMed ID: 18156920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
